Koers Hypertension Diagnostics, Inc.
Aandelen
HDII
US44914V1044
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | -.--% |
|
-.--% | -99,90% |
Omzet 2017 | 3,68 mln. 3,39 mln. | Omzet 2018 | 3,79 mln. 3,5 mln. | Marktkapitalisatie | 92,08K 84,97K |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 | Nettowinst (verlies) 2018 | - 0 | EV/omzet 2017 | 1,15 x |
Nettoschuld 2017 | 4,13 mln. 3,81 mln. | Nettoschuld 2018 | 4,6 mln. 4,24 mln. | EV/omzet 2018 | 1,24 x |
K/w-verhouding 2017 |
-0,28
x | K/w-verhouding 2018 |
-0,54
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-99,90% | 284 | |
+1,75% | 206 mld. | |
+3,42% | 177 mld. | |
+31,54% | 157 mld. | |
+32,16% | 112 mld. | |
+21,08% | 55,63 mld. | |
-1,61% | 47,57 mld. | |
-9,11% | 36,87 mld. | |
-0,34% | 35,18 mld. | |
+13,21% | 28,61 mld. |